ストックスクリーナーアプリを入手
0.7678
10.32%
0.0718
アフターアワーズ：
.70
-0.0678
-8.83%
前日終値:
$0.696
開ける：
$0.696149
24時間の取引高:
59,094
Relative Volume:
0.78
時価総額：
$36.39M
収益：
$16.18M
当期純損益:
$-11.58M
株価収益率:
-3.7344
EPS:
-0.2056
ネットキャッシュフロー:
$98,700
1週間 パフォーマンス:
+13.40%
1か月 パフォーマンス:
-7.55%
6か月 パフォーマンス:
-32.65%
1年 パフォーマンス:
-86.14%
1日の値動き範囲:
$0.6801
$0.769
1週間の範囲:
$0.6155
$0.769
52週間の値動き範囲:
$0.6155
$13.08
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Compare ZYBT vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
0.7678 | 32.98M | 16.18M | -11.58M | 98,700 | -0.2056 |
TAK
Takeda Pharmaceutical Co Adr
|
16.96 | 53.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.84 | 42.80B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.65 | 41.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.29 | 31.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
563.70 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Zhengye Biotechnology Holding Ltd (ZYBT) 最新ニュース
AI Models Turn Less Negative on ZYBT but Keep Risk Warnings in Place - TipRanks
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Zhengye Biotechnology Holding Ltd (ZYBT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Institutional Confidence - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Zhengye Biotechnology Holding Ltd - TradingKey
Zhengye Biotechnology receives Nasdaq bid price deficiency notice By Investing.com - Investing.com Australia
Zhengye Biotechnology receives Nasdaq bid price deficiency notice - Investing.com UK
Zhengye Biotechnology Receives Nasdaq Letter for Minimum Bid Price Deficiency - marketscreener.com
Zhengye Biotechnology Faces Nasdaq Minimum Bid Price Deficiency After May 29 Notice - TipRanks
Zhengye Biotech has 6 months to lift stock back above $1 - Stock Titan
Zhengye Biotech's Nasdaq Lifeline: A 180-Day Race Against Financial Reality - BriefGlance
ZYBTZhengye Biotechnology Holding Ltd Stock Price and Quote - Finviz
ZYBT Stock Price, Quote & Chart | ZHENGYE BIOTECHNOLOGY-A (NASDAQ:ZYBT) - ChartMill
TradingKey - TradingKey
Zhengye (ZYBT) quarterly report delayed as CEO highlights strategic priorities; investors await key financial data. - The Legal Advocate
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results - Tirto.id
China hog slump hits Zhengye as vaccine maker posts annual loss - Stock Titan
How risky is Zhengye (ZYBT) stock investment? (Institutional Selling) 2026-04-27Earnings Beat Stocks - newser.com
ZYBT Price Today: Zhengye Biotechnology Holding Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
Why Zhengye (ZYBT) Stock Could Rise (+3.79%) 2026-04-20Retail Picks - newser.com
Aiden Han Net Worth (2026) - GuruFocus
Wei Lian Net Worth (2026) - GuruFocus
Zhongyao Liu Net Worth (2026) - GuruFocus
Wenhua Sun Net Worth (2026) - GuruFocus
Zhengye Biotechnology posts $0.24 EPS $186M revenue no estimatesShort-Term Outlook - The Legal Advocate
Trading Recap: Will Zhengye Biotechnology Holding Limited stock hit new highs in YEARQuarterly Trade Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Zhengye Biotechnology implements dual-class share structure - Investing.com
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure - Weekly Voice
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure Effective April 7, 2026 - Quiver Quantitative
Zhengye's new share classes give some holders 20 votes each - Stock Titan
ZYBT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ZYBT Technical Analysis & Stock Price Forecast - Intellectia AI
Death Cross: How does Zhengye Biotechnology Holding Limited correlate with NasdaqInflation Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Zhengye Biotechnology Shareholders Approve Governance and Share Structure Changes at March 24 AGM - TipRanks
Why Faraday Future Intelligent Electric Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket - Benzinga
$Zhengye Biotechnology (ZYBT.US)$ still hodl some for moon - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Kyverna Therapeutics (NASDAQ:KYTX) and Zhengye Biotechnology (NASDAQ:ZYBT) Critical Contrast - Defense World
ZYBT Should I Buy - Intellectia AI
Zhengye Biotechnology Director Resigns, Nasdaq Independence Deficiency to Be Addressed at March AGM - TipRanks
Zhengye Biotechnology Holding Limited Announces Resignation of Wenbin Wang as Independent Director, Member of Committees, and Chairperson of the Compensation Committee, Effective February 18, 2026 - marketscreener.com
Will Zhengye Biotechnology Holding Limited benefit from geopolitical trendsChart Signals & Trade Opportunity Analysis Reports - mfd.ru
Zhengye Biotech chairman outlines 2025 achievements, 2026 strategy By Investing.com - Investing.com South Africa
Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to Shareholders - GlobeNewswire
Zhengye Biotechnology Holding Ltd (ZYBT) 財務データ
収益
当期純利益
現金流量
EPS
0.17%
1.98%
大文字化:
|
ボリューム (24 時間):